Negatively correlated with PD-L1 expression in NSCLC tissues thus may improve predictive value beyond PD-L1 tumor proportion scores (TPS) for selecting patients for immune checkpoint inhibitor therapy. Here, CD274 is linked to non-small cell lung carcinoma.